Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes

被引:2
作者
Abiose, Olamide [1 ,2 ,9 ]
Rutledge, Jarod [3 ,4 ]
Moran-Losada, Patricia [1 ,2 ,3 ]
Belloy, Michael E. [1 ]
Wilson, Edward N. [1 ,2 ]
He, Zihuai [1 ,5 ]
Trelle, Alexandra N. [1 ]
Channappa, Divya [1 ]
Romero, America [1 ]
Park, Jennifer [1 ]
Yutsis, Maya V. [1 ]
Sha, Sharon J. [1 ]
Andreasson, Katrin I. [1 ,2 ,6 ]
Poston, Kathleen L. [1 ,2 ,3 ]
Henderson, Victor W. [1 ,7 ]
Wagner, Anthony D. [2 ,8 ]
Wyss-Coray, Tony [1 ,2 ,3 ]
Mormino, Elizabeth C. [1 ,2 ,9 ]
机构
[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA USA
[2] Stanford Univ, Sch Med, Wu Tsai Neurosci Inst, Stanford, CA USA
[3] Stanford Univ, Phil & Penny Knight Initiat Brain Resilience, Stanford, CA USA
[4] Stanford Univ, Dept Genet, Stanford, CA USA
[5] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA USA
[6] Chan Zuckerberg Biohub, San Francisco, CA USA
[7] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA USA
[8] Stanford Univ, Dept Psychol, Stanford, CA USA
[9] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 453 Quarry Rd, Palo Alto, CA 94304 USA
关键词
aging; Alzheimer's disease; autophagy; cerebral spinal fluid; clinically unimpaired; protein co-expression network; ubiquitination; AMYLOID-BETA; A-BETA; TAU; AUTOPHAGY; BRAIN; INDIVIDUALS; ASSOCIATION; BIOMARKERS; MECHANISM; PROTEINS;
D O I
10.1002/alz.13576
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: In this study, we leverage proteomic techniques to identify communities of proteins underlying Alzheimer's disease (AD) risk among clinically unimpaired (CU) older adults.METHODS: We constructed a protein co-expression network using 3869 cerebrospinal fluid (CSF) proteins quantified by SomaLogic, Inc., in a cohort of participants along the AD clinical spectrum. We then replicated this network in an independent cohort of CU older adults and related these modules to clinically-relevant outcomes.RESULTS: We discovered modules enriched for phosphorylation and ubiquitination that were associated with abnormal amyloid status, as well as p-tau181 (M4: beta = 2.44, p < 0.001, M7: beta = 2.57, p < 0.001) and executive function performance (M4: beta = -2.00, p = 0.005, M7: beta = -2.39, p < 0.001).DISCUSSION: In leveraging CSF proteomic data from individuals spanning the clinical spectrum of AD, we highlight the importance of post-translational modifications for early cognitive and pathological changes.
引用
收藏
页码:1851 / 1867
页数:17
相关论文
共 50 条
  • [31] Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility
    Mortamais, Marion
    Ash, Jessica A.
    Harrison, John
    Kaye, Jeffrey
    Kramer, Joel
    Randolph, Christopher
    Pose, Carine
    Albala, Bruce
    Ropacki, Michael
    Ritchie, Craig W.
    Ritchie, Karen
    ALZHEIMERS & DEMENTIA, 2017, 13 (04) : 468 - 492
  • [32] The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease
    Wang, Yan
    Lin, Fang
    Qin, Zheng-Hong
    NEUROSCIENCE BULLETIN, 2010, 26 (02) : 153 - 162
  • [33] Longitudinal brain structural changes in preclinical Alzheimer's disease
    Pegueroles, Jordi
    Vilaplana, Eduard
    Montal, Victor
    Sampedro, Frederic
    Alcolea, Daniel
    Carmona-Iragui, Maria
    Clarimon, Jordi
    Blesa, Rafael
    Lleo, Alberto
    Fortea, Juan
    ALZHEIMERS & DEMENTIA, 2017, 13 (05) : 499 - 509
  • [34] Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies
    Kametani, Fuyuki
    Yoshida, Mari
    Matsubara, Tomoyasu
    Murayama, Shigeo
    Saito, Yuko
    Kawakami, Ito
    Onaya, Mitsumoto
    Tanaka, Hidetomo
    Kakita, Akiyoshi
    Robinson, Andrew C.
    Mann, David M. A.
    Hasegawa, Masato
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [35] Alzheimer's Disease-Related Analytes Amyloid-β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score
    Walia, Amit
    Shew, Matthew A.
    Durakovic, Nedim
    Herzog, Jacques A.
    Cirrito, John R.
    Yuede, Carla M.
    Wick, Cameron C.
    Manis, Melissa
    Holtzman, David M.
    Buchman, Craig A.
    Rutherford, Mark A.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 171 (06) : 1850 - 1858
  • [36] Alzheimer's Disease-Related Lesions
    Alafuzoff, Irina
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S173 - S179
  • [37] Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies
    Bilgel, Murat
    Koscik, Rebecca L.
    An, Yang
    Prince, Jerry L.
    Resnick, Susan M.
    Johnson, Sterling C.
    Jedynak, Bruno M.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 59 (04) : 1335 - 1347
  • [38] Post-translational processing of beta-secretase in Alzheimer's disease
    Sidera, C
    Parsons, R
    Austen, B
    PROTEOMICS, 2005, 5 (06) : 1533 - 1543
  • [39] PTMD: A Database of Human Disease-associated Post-translational Modifications
    Xu, Haodong
    Wang, Yongbo
    Lin, Shaofeng
    Deng, Wankun
    Peng, Di
    Cui, Qinghua
    Xue, Yu
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2018, 16 (04) : 244 - 251
  • [40] Identifying Alzheimer's disease-related proteins by LRRGD
    Zhao, Tianyi
    Hu, Yang
    Zang, Tianyi
    Cheng, Liang
    BMC BIOINFORMATICS, 2019, 20 (Suppl 18)